A377740 logo

BioNote, Inc. Stock Price

KOSE:A377740 Community·₩469.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A377740 Share Price Performance

₩4,640.00
-390.00 (-7.75%)
₩4,640.00
-390.00 (-7.75%)
Price ₩4,640.00

A377740 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

2 Risks
0 Rewards

BioNote, Inc. Key Details

₩122.4b

Revenue

₩52.8b

Cost of Revenue

₩69.6b

Gross Profit

₩119.8b

Other Expenses

-₩50.2b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-496.35
56.84%
-41.02%
0%
View Full Analysis

About A377740

Founded
2003
Employees
n/a
CEO
ByeongGi Cho
WebsiteView website
www.bionote.co.kr

BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwaseong-si, South Korea.

Recent A377740 News & Updates

Recent updates

No updates